EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
BioAge Labs, Inc. (BIOA) had EBIT Margin of -915.40% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.77M |
|
$-22.25M |
|
-- |
|
$2.77M |
|
$28.15M |
|
$-25.38M |
|
$3.12M |
|
$-22.25M |
|
$-22.25M |
|
$-22.25M |
|
$-22.25M |
|
$-22.25M |
|
$-22.25M |
|
$-25.38M |
|
$-25.31M |
|
42.48M |
|
42.48M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$391.86M |
|
$1.11M |
|
$5.79M |
|
$397.65M |
|
$15.83M |
|
-- |
|
$2.71M |
|
$18.53M |
|
$379.12M |
|
$379.12M |
|
$379.12M |
|
44.39M |
|
| Cash Flow Statement Financials | |
$-24.05M |
|
$-46.75M |
|
$123.72M |
|
$188.89M |
|
$241.78M |
|
$52.89M |
|
$4.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.76 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-915.40% |
|
|
EBIT Margin |
-915.40% |
-- |
|
-802.78% |
|
-802.78% |
|
$-24.07M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
3.91 |
|
23.02 |
|
-5.87% |
|
-5.87% |
|
-5.60% |
|
-5.87% |
|
$8.54 |
|
$-0.57 |
|
$-0.57 |
|